Nuhad Ibrahim Selected Research

tariquidar (XR9576)

8/2005

Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nuhad Ibrahim Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 11/2023 - 07/2003
15	Neoplasms (Cancer) 01/2023 - 03/2003
8	Brain Neoplasms (Brain Tumor) 11/2023 - 03/2016
5	Disease Progression 11/2023 - 01/2009
4	Neoplasm Metastasis (Metastasis) 11/2023 - 01/2013
4	Triple Negative Breast Neoplasms 06/2023 - 11/2011
3	Pathologic Complete Response 01/2011 - 08/2005
2	Diarrhea 01/2020 - 03/2016
2	Neurologic Manifestations (Neurological Manifestations) 01/2019 - 03/2016
1	Residual Neoplasm 01/2023
1	Meningeal Carcinomatosis 01/2020
1	Central Nervous System Diseases (CNS Diseases) 03/2016
1	Carcinogenesis 08/2015
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Infections 01/2011
1	Febrile Neutropenia 01/2011
1	Arthralgia (Joint Pain) 02/2004
1	Fatigue 02/2004
1	Fever (Fevers) 07/2003
1	Cardiotoxicity 07/2003
1	Leukemia 03/2003

Drug/Important Bio-Agent (IBA)

5	Trastuzumab (Herceptin)FDA Link 11/2023 - 07/2003
5	AnthracyclinesIBA 06/2023 - 04/2006
5	taxaneIBA 07/2019 - 08/2005
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 07/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2011 - 02/2004
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2009
3	pertuzumabIBA 11/2023 - 01/2021
3	human ERBB2 proteinIBA 10/2023 - 03/2016
3	ErbB Receptors (EGF Receptor)IBA 10/2020 - 03/2016
3	neratinibIBA 01/2020 - 03/2016
3	Peptides (Polypeptides)IBA 01/2020 - 01/2009
3	Fluorouracil (Carac)FDA LinkGeneric 01/2011 - 08/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 09/2006 - 02/2004
2	etirinotecan pegolIBA 01/2022 - 07/2019
2	Hormones (Hormone)IBA 10/2020 - 01/2009
2	Estrogen ReceptorsIBA 10/2020 - 05/2011
2	Capecitabine (Xeloda)FDA Link 07/2019 - 01/2019
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011 - 07/2003
1	130-nm albumin-bound paclitaxelIBA 06/2023
1	atezolizumabIBA 06/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	talimogene laherparepvecIBA 11/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Radioisotopes (Radionuclides)IBA 01/2021
1	talazoparibIBA 10/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	paclitaxel-Angiopep-2 conjugateIBA 01/2020
1	SteroidsIBA 01/2019
1	Loperamide (Imodium)FDA LinkGeneric 03/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2016
1	Epirubicin (Ellence)FDA LinkGeneric 08/2015
1	dinaciclibIBA 08/2015
1	Cyclin EIBA 08/2015
1	Protein Isoforms (Isoforms)IBA 08/2015
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2012
1	GalactosyltransferasesIBA 12/2012
1	GlycopeptidesIBA 12/2012
1	EpitopesIBA 12/2012
1	Polysaccharides (Glycans)IBA 12/2012
1	MucinsIBA 12/2012
1	AntigensIBA 12/2012
1	Indicators and Reagents (Reagents)IBA 12/2012
1	Monoclonal AntibodiesIBA 12/2012
1	Dasatinib (BMS 354825)FDA Link 11/2011
1	src-Family KinasesIBA 11/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2009
1	epitumomabIBA 01/2009
1	VaccinesIBA 01/2009
1	DNA VaccinesIBA 01/2009
1	rubitecanIBA 04/2006
1	CamptothecinIBA 04/2006
1	Albumin-Bound Paclitaxel FDA Link 01/2006
1	Phenobarbital (Luminal)FDA Link 08/2005
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2005
1	tariquidar (XR9576)IBA 08/2005
1	CytokinesIBA 02/2004
1	Interleukin-10 (Interleukin 10)IBA 02/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2003
1	Docetaxel (Taxotere)FDA Link 07/2003
1	Clofarabine (Clolar)FDA Link 03/2003

Therapy/Procedure

10	Therapeutics 10/2023 - 07/2003
10	Drug Therapy (Chemotherapy) 01/2022 - 02/2004
4	Radiotherapy 11/2023 - 03/2016
3	Neoadjuvant Therapy 01/2023 - 01/2011
2	Immunotherapy 11/2021 - 01/2009
1	Craniotomy 01/2020